Asymptomatic HIV testing in Cappella Maggiore

Find health labs to test for Asymptomatic HIV in Cappella Maggiore and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Roma, 11 31016 Cordignano (TV)

2.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Venezia, 59 31020 San Vendemiano (TV)

5.5 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Sandi, 2 32014 Puos d'Alpago (BL)

10.9 km

Unverified

See Details

Rapid HIV Test by Centro di medicina

Via della Ferriera, 22, 33170 Pordenone PN, Italia

14.3 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via I. Caffi, 132 32100 Belluno (BL)

13.6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Caduti 14 settembre 1944, 39/B Belluno (BL) 39 Belluno (BL)

13.6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Postumia, 153 c/o Poliambulatorio Vitamedica 31038 Paese (TV)

22.9 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Viale delle Industrie n. 13 31030 Dosson di Casier (TV)

23.7 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Roma, 93/C 30020 Quarto d'Altino (VE)

26.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Loc. Valcozzena, 31/M 32021 Agordo (BL)

26.7 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.